UPPALURI SUBBARAO V 4

What Happened Uppaluri Subbarao V, a director of OPKO Health, reported receiving an award/other acquisition of 50,000 shares (classified as a derivative) on March 18, 2026. The filing shows an acquisition price of $0.00 for the award (i.e., no cash paid per the Form 4). This is an equity grant/award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-18; Form 4 filed: 2026-03-20 (filed two days after the transaction).
• Transaction type/code: A (Award/Grant or Other Acquisition) — derivative security reported.
• Shares acquired: 50,000; price reported: $0.00.
• Total cash paid per filing: $0.00 (no purchase price disclosed).
• Shares owned after transaction: not specified in the reported Form 4.
• No 10b5-1 plan, tax-withholding, or other footnotes were disclosed in the summary information provided.

Context This filing reports an equity award to a company director. Such awards are typically compensation or incentive grants (e.g., restricted stock units or similar), and are different from open-market purchases or sales. The Form 4 was filed shortly after the transaction date; there is no indication in the filing summary that it was late. As with all insider filings, the transaction is factual disclosure of ownership change and does not, by itself, indicate the director’s market view.